With promise to slow aging and cure some types of cancer, a new gene therapy presents cost and access hurdles for CT patients.
Detailed price information for Ultragenyx Pharmaceu (RARE-Q) from The Globe and Mail including charting and trades.
Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...
Chantez Sanford Jr., 24, of Southfield, says his life has been transformed after undergoing Lyfgenia gene therapy at Children ...
The movement-related benefits of Itvisma were maintained or continued to deepen over about 15 months after treatment, trial ...
UAB is participating in a Phase I/II trial of AMT 191, a one time gene therapy designed to enable patients with classic Fabry disease to produce their own missing enzyme, potentially reducing the need ...
A single dose of experimental gene therapy GS001 reduced bleeding episodes in men with severe hemophilia A, a study showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results